{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Cancer+Terminal&page=3", "query": { "condition": "Cancer Terminal", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 60, "total_pages": 6, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Cancer+Terminal&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Cancer+Terminal&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-29T15:01:00.341Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00062621", "title": "Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney Failure", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Kidney Failure, Chronic", "Multiple Myeloma" ], "interventions": [ { "name": "Combined bone marrow and kidney transplant", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 5, "start_date": "2003-06", "completion_date": "2006-12", "has_results": false, "last_update_posted_date": "2013-02-05", "last_synced_at": "2026-10-29T15:01:00.341Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00062621" }, { "nct_id": "NCT00375011", "title": "Breath Test to Assess Hepatic Metabolic Reserve and to Predict Hepatic Decompensation in Cirrhotics", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cirrhosis" ], "interventions": [], "intervention_types": [], "sponsor": "Meridian Bioscience, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 200, "start_date": "2008-09", "completion_date": "2011-10", "has_results": false, "last_update_posted_date": "2022-12-20", "last_synced_at": "2026-10-29T15:01:00.341Z", "location_count": 2, "location_summary": "Richmond, Virginia", "locations": [ { "city": "Richmond", "state": "Virginia" }, { "city": "Richmond", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00375011" }, { "nct_id": "NCT00854139", "title": "Combined Bone Marrow Transplantation (BMT) and Renal Transplant for Multiple Myeloma (MM) With End Stage Renal Disease (ESRD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Multiple Myeloma", "End Stage Renal Disease" ], "interventions": [ { "name": "Cyclophosphamide, anti-thymocyte globulin", "type": "DRUG" }, { "name": "Kidney transplant", "type": "PROCEDURE" }, { "name": "Thymic irradiation", "type": "RADIATION" }, { "name": "Bone marrow transplant from a related donor", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE", "RADIATION" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 10, "start_date": "2001-08", "completion_date": "2014-07", "has_results": false, "last_update_posted_date": "2020-03-04", "last_synced_at": "2026-10-29T15:01:00.341Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00854139" }, { "nct_id": "NCT02093871", "title": "A Phase 1 Trial of Perfusion Induced Systemic Hyperthermia (PISH) Over Multiple Cycles for Terminal Ovarian Cancer", "overall_status": "SUSPENDED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Ovarian Cancer" ], "interventions": [ { "name": "ThermalCore Hyperthermia System", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "ThermalCore Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "69 Years", "sex": "ALL", "summary": "18 Years to 69 Years" }, "enrollment_count": 20, "start_date": "2013-08", "completion_date": "2018-06", "has_results": false, "last_update_posted_date": "2017-07-21", "last_synced_at": "2026-10-29T15:01:00.341Z", "location_count": 1, "location_summary": "San Jose, California", "locations": [ { "city": "San Jose", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02093871" }, { "nct_id": "NCT01358617", "title": "Prognostic Biomarkers in Tumor Tissue Samples From Young Patients With Neuroblastoma", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Disseminated Neuroblastoma", "Localized Resectable Neuroblastoma", "Localized Unresectable Neuroblastoma", "Recurrent Neuroblastoma", "Stage 4S Neuroblastoma" ], "interventions": [ { "name": "diagnostic laboratory biomarker analysis", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Children's Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 90, "start_date": "2011-05", "completion_date": "2011-08", "has_results": false, "last_update_posted_date": "2015-05-12", "last_synced_at": "2026-10-29T15:01:00.341Z", "location_count": 1, "location_summary": "Monrovia, California", "locations": [ { "city": "Monrovia", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01358617" }, { "nct_id": "NCT03936465", "title": "Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Solid Tumor, Childhood", "Lymphoma", "Brain Tumor, Pediatric" ], "interventions": [ { "name": "BMS-986158", "type": "DRUG" }, { "name": "BMS-986378", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dana-Farber Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "21 Years", "sex": "ALL", "summary": "1 Year to 21 Years" }, "enrollment_count": 41, "start_date": "2019-09-27", "completion_date": "2024-10-01", "has_results": false, "last_update_posted_date": "2024-10-02", "last_synced_at": "2026-10-29T15:01:00.341Z", "location_count": 5, "location_summary": "Boston, Massachusetts • Ann Arbor, Michigan • Durham, North Carolina + 2 more", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT03936465" }, { "nct_id": "NCT03886753", "title": "Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "ALS", "Autism Spectrum Disorder", "Cancer", "Spasticity, Muscle", "Dyskinetic Syndrome", "Epilepsy", "Glaucoma", "Huntington Disease", "Inflammatory Bowel Disease (IBD)", "Multiple Sclerosis", "Neuropathy", "Opioid Use", "Parkinson Disease", "HIV/AIDS", "Ptsd", "Intractable Pain", "Sickle Cell Disease", "Terminal Illness" ], "interventions": [ { "name": "Registry", "type": "OTHER" }, { "name": "PK microsampling of blood", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Children's Hospital of Philadelphia", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 10, "start_date": "2019-05-15", "completion_date": "2020-06-30", "has_results": false, "last_update_posted_date": "2020-07-30", "last_synced_at": "2026-10-29T15:01:00.341Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT03886753" }, { "nct_id": "NCT01463852", "title": "A Study of the Effect of Vinca Alkaloids on c-Jun N-terminal Kinase (JNK) Phosphorylation in Patients With Chronic Lymphocytic Leukemia (CLL)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Chronic Lymphocytic Leukemia (CLL)" ], "interventions": [ { "name": "vincristine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dartmouth-Hitchcock Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 11, "start_date": "2012-10", "completion_date": "2014-12", "has_results": false, "last_update_posted_date": "2015-05-12", "last_synced_at": "2026-10-29T15:01:00.341Z", "location_count": 1, "location_summary": "Lebanon, New Hampshire", "locations": [ { "city": "Lebanon", "state": "New Hampshire" } ], "official_url": "https://clinicaltrials.gov/study/NCT01463852" }, { "nct_id": "NCT01933789", "title": "Improving Communication About Serious Illness", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Critical Illness", "Chronic Disease", "Terminal Care", "Palliative Care", "Communication", "Advance Care Planning", "Neoplasm Metastasis", "Lung Neoplasms", "Pulmonary Disease, Chronic Obstructive", "Heart Failure", "End Stage Liver Disease", "Kidney Failure, Chronic" ], "interventions": [ { "name": "Communication Feedback Form for Patients with Serious Illness", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 817, "start_date": "2013-09", "completion_date": "2016-12", "has_results": true, "last_update_posted_date": "2019-03-20", "last_synced_at": "2026-10-29T15:01:00.341Z", "location_count": 6, "location_summary": "Renton, Washington • Seattle, Washington", "locations": [ { "city": "Renton", "state": "Washington" }, { "city": "Seattle", "state": "Washington" }, { "city": "Seattle", "state": "Washington" }, { "city": "Seattle", "state": "Washington" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT01933789" }, { "nct_id": "NCT03694431", "title": "Comparative Trial of Home-Based Palliative Care", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cancer", "Chronic Obstructive Pulmonary Disease", "Heart Failure", "Dementia", "End Stage Liver Disease", "End Stage Renal Disease", "Neuromuscular Diseases" ], "interventions": [ { "name": "Tech-supported HBPC", "type": "OTHER" }, { "name": "Standard HBPC", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Kaiser Permanente", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 3999, "start_date": "2019-01-07", "completion_date": "2020-01-24", "has_results": false, "last_update_posted_date": "2020-02-20", "last_synced_at": "2026-10-29T15:01:00.341Z", "location_count": 2, "location_summary": "Pasadena, California • Portland, Oregon", "locations": [ { "city": "Pasadena", "state": "California" }, { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT03694431" } ] }